Our Mission at GNT Animal Health
We aim to provide products that go beyond merely treating and controlling animal diseases.
R&D
Certificate
Patent
Patent
Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the
central nervous system
Country
KR, US, EP, CN, JP, CA, AU, etc.
Patent
Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
Country
KR, US, EP, CN, JP, CA, AU, etc.
Patent
Compositions and methods for treating neurodegenerative disorders
Country
Pending – US & PCT
Patent
Composition and Method for Treating Autoimmune Diseases
Country
South Korea
Publication
Publication
Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2
production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis
Publication
AAD-2004 attenuates progressive neuronal loss in the brain of Tg-betaCTF99/B6 mouse model of Alzheimer
disease
Publication
Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via
H2O2-production
Publication
Potent Analgesic Action of 2-acetoxy-5-(2-4 (trifluoromethyl)-phenethylamino)-benzoic Acid (Flusalazine)
in Experimental Mice
Publication
Off-Label Use of Crisdesalazine (GedaCure) in Meningoencephalitis in Two Dogs
Publication
Prevalence and risk factors of canine cognitive dysfunction syndrome in South Korea
Certification
-
Certificate of Authorization - Research Institute -
Certificate of Registration - Animal Experiment Facility -
Certificate of Product Registration -
Certificate of Manufacture -
Certificate of Trademark Registration -
Certificate of Trademark Registration -
Certificate of Trademark Registration -
Certificate of Trademark Registration